We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
101
Walt Disney
DIS
$172B
$32.2M 0.22%
356,720
+77,166
+28% +$6.8M
BIO icon
102
Bio-Rad Laboratories Class A
BIO
$8.86B
$32.1M 0.22%
99,324
+26,202
+36% +$8.21M
Z icon
103
Zillow
Z
$7.7B
$32M 0.22%
+552,919
New +$24.4M
IONS icon
104
Ionis Pharmaceuticals
IONS
$9.14B
$31.8M 0.22%
629,067
+80,000
+15% +$3.83M
MDB icon
105
MongoDB
MDB
$25B
$31.5M 0.22%
77,113
+32,187
+72% +$12.2M
INTC icon
106
Intel
INTC
$435B
$31.3M 0.22%
622,702
+319,913
+106% +$13M
PH icon
107
Parker-Hannifin
PH
$125B
$31.2M 0.22%
67,638
+19,425
+40% +$8.09M
KLAC icon
108
KLA
KLAC
$249B
$30.9M 0.21%
531,630
+43,950
+9% +$2.29M
DDOG icon
109
Datadog
DDOG
$89.3B
$30.9M 0.21%
254,591
+56,130
+28% +$5.78M
BMY icon
110
Bristol-Myers Squibb
BMY
$130B
$30.7M 0.21%
598,677
+186,370
+45% +$9.78M
KO icon
111
Coca-Cola
KO
$380B
$30.7M 0.21%
520,792
-84,602
-14% -$4.81M
A icon
112
Agilent Technologies
A
$39.7B
$30.2M 0.21%
217,407
-36,047
-14% -$4.29M
XYL icon
113
Xylem
XYL
$29.7B
$30.2M 0.21%
263,749
+62,736
+31% +$6.26M
CAT icon
114
Caterpillar
CAT
$387B
$30.1M 0.21%
101,657
+37,052
+57% +$9.61M
LNTH icon
115
Lantheus
LNTH
$6.68B
$30M 0.21%
483,088
-31,373
-6% -$2.13M
CTAS icon
116
Cintas
CTAS
$86B
$29.5M 0.2%
195,500
-1,060
-0.5% -$142K
PLD icon
117
Prologis
PLD
$137B
$28.9M 0.2%
217,166
+64,451
+42% +$7.32M
BSX icon
118
Boston Scientific
BSX
$68.5B
$28.2M 0.19%
487,499
+43,268
+10% +$2.31M
INTU icon
119
Intuit
INTU
$85.6B
$27.8M 0.19%
44,482
+12,126
+37% +$6.69M
BMRN icon
120
BioMarin Pharmaceuticals
BMRN
$12B
$27.7M 0.19%
286,928
-61,621
-18% -$5.45M
HCA icon
121
HCA Healthcare
HCA
$92.8B
$26.7M 0.18%
98,600
+17,429
+21% +$4.31M
TAL icon
122
TAL Education Group
TAL
$5.79B
$26.5M 0.18%
+2,098,800
New +$21.7M
ILMN icon
123
Illumina
ILMN
$29.2B
$26.1M 0.18%
192,525
+31,008
+19% +$3.58M
CNC icon
124
Centene
CNC
$31.6B
$25.7M 0.18%
346,429
+19,270
+6% +$1.39M
VZ icon
125
Verizon
VZ
$201B
$25.6M 0.18%
679,778
+669,827
+6,731% +$23.7M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.